Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea May

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Cancer Medicine|January 20, 2016
The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma riskJessica Becker, Andrea May, Christian Gerges, et al.
Cancer Medicine|September 19, 2015
Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinomaJessica Becker, Andrea May, Christian Gerges, et al.
Gastroenterology|September 12, 2020
Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal AdenocarcinomaJing Dong, Carlo Maj, Spiridon Tsavachidis, et al.
Gut|January 5, 2018
Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complicationsAngelika Behrens, Anton Kreuzmayr, Hendrik Manner, et al.
Plos One|September 20, 2023
Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant periodMaya R Sternberg, Amelia Johnson, Justice King, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2019
No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization StudyJing Dong, Puya Gharahkhani, Wong-Ho Chow, et al.
Gut|July 26, 2022
GWAS meta-analysis of 16 790 patients with Barrett's oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker levelJulia Schröder, Laura Chegwidden, Carlo Maj, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021Amelia G Johnson, Avnika B Amin, Akilah R Ali, et al.
The Lancet. Oncology|August 17, 2016
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysisPuya Gharahkhani, Rebecca C Fitzgerald, Thomas L Vaughan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2022
eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal AdenocarcinomaXiaoyu Wang, Puya Gharahkhani, David M Levine, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Cancer Medicine|January 20, 2016
The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma riskJessica Becker, Andrea May, Christian Gerges, et al.
Cancer Medicine|September 19, 2015
Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinomaJessica Becker, Andrea May, Christian Gerges, et al.
Gastroenterology|September 12, 2020
Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal AdenocarcinomaJing Dong, Carlo Maj, Spiridon Tsavachidis, et al.
Gut|January 5, 2018
Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complicationsAngelika Behrens, Anton Kreuzmayr, Hendrik Manner, et al.
Plos One|September 20, 2023
Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant periodMaya R Sternberg, Amelia Johnson, Justice King, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2019
No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization StudyJing Dong, Puya Gharahkhani, Wong-Ho Chow, et al.
Gut|July 26, 2022
GWAS meta-analysis of 16 790 patients with Barrett's oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker levelJulia Schröder, Laura Chegwidden, Carlo Maj, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021Amelia G Johnson, Avnika B Amin, Akilah R Ali, et al.
The Lancet. Oncology|August 17, 2016
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysisPuya Gharahkhani, Rebecca C Fitzgerald, Thomas L Vaughan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2022
eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal AdenocarcinomaXiaoyu Wang, Puya Gharahkhani, David M Levine, et al.
Pageof 11